Literature DB >> 21814181

Severe serotonin depletion after conditional deletion of the vesicular monoamine transporter 2 gene in serotonin neurons: neural and behavioral consequences.

Nicolas Narboux-Nême1, Corinne Sagné, Stephane Doly, Silvina L Diaz, Cédric B P Martin, Gaelle Angenard, Marie-Pascale Martres, Bruno Giros, Michel Hamon, Laurence Lanfumey, Patricia Gaspar, Raymond Mongeau.   

Abstract

The vesicular monoamine transporter type 2 gene (VMAT2) has a crucial role in the storage and synaptic release of all monoamines, including serotonin (5-HT). To evaluate the specific role of VMAT2 in 5-HT neurons, we produced a conditional ablation of VMAT2 under control of the serotonin transporter (slc6a4) promoter. VMAT2(sert-cre) mice showed a major (-95%) depletion of 5-HT levels in the brain with no major alterations in other monoamines. Raphe neurons contained no 5-HT immunoreactivity in VMAT2(sert-cre) mice but developed normal innervations, as assessed by both tryptophan hydroxylase 2 and 5-HT transporter labeling. Increased 5-HT(1A) autoreceptor coupling to G protein, as assessed with agonist-stimulated [(35)S]GTP-γ-S binding, was observed in the raphe area, indicating an adaptive change to reduced 5-HT transmission. Behavioral evaluation in adult VMAT2(sert-cre) mice showed an increase in escape-like reactions in response to tail suspension and anxiolytic-like response in the novelty-suppressed feeding test. In an aversive ultrasound-induced defense paradigm, VMAT2(sert-cre) mice displayed a major increase in escape-like behaviors. Wild-type-like defense phenotype could be rescued by replenishing intracellular 5-HT stores with chronic pargyline (a monoamine oxidase inhibitor) treatment. Pargyline also allowed some form of 5-HT release, although in reduced amounts, in synaptosomes from VMAT2(sert-cre) mouse brain. These findings are coherent with the notion that 5-HT has an important role in anxiety, and provide new insights into the role of endogenous 5-HT in defense behaviors.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21814181      PMCID: PMC3194080          DOI: 10.1038/npp.2011.142

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  70 in total

1.  Nonvesicular inhibitory neurotransmission via reversal of the GABA transporter GAT-1.

Authors:  Yuanming Wu; Wengang Wang; Ana Díez-Sampedro; George B Richerson
Journal:  Neuron       Date:  2007-12-06       Impact factor: 17.173

2.  Monoaminergic mechanisms in aversive brain stimulation.

Authors:  R S Kiser; R M Lebovitz
Journal:  Physiol Behav       Date:  1975-07

3.  Knockout of the vesicular monoamine transporter 2 gene results in neonatal death and supersensitivity to cocaine and amphetamine.

Authors:  Y M Wang; R R Gainetdinov; F Fumagalli; F Xu; S R Jones; C B Bock; G W Miller; R M Wightman; M G Caron
Journal:  Neuron       Date:  1997-12       Impact factor: 17.173

4.  Plasma membrane transporters of serotonin, dopamine, and norepinephrine mediate serotonin accumulation in atypical locations in the developing brain of monoamine oxidase A knock-outs.

Authors:  O Cases; C Lebrand; B Giros; T Vitalis; E De Maeyer; M G Caron; D J Price; P Gaspar; I Seif
Journal:  J Neurosci       Date:  1998-09-01       Impact factor: 6.167

5.  Neural correlates of competing fear behaviors evoked by an innately aversive stimulus.

Authors:  Raymond Mongeau; Gabriel A Miller; Elizabeth Chiang; David J Anderson
Journal:  J Neurosci       Date:  2003-05-01       Impact factor: 6.167

Review 6.  The spectrum of behaviors influenced by serotonin.

Authors:  I Lucki
Journal:  Biol Psychiatry       Date:  1998-08-01       Impact factor: 13.382

Review 7.  Serotonin, the periaqueductal gray and panic.

Authors:  Frederico G Graeff
Journal:  Neurosci Biobehav Rev       Date:  2004-05       Impact factor: 8.989

8.  Differential long-term effects of MDMA on the serotoninergic system and hippocampal cell proliferation in 5-HTT knock-out vs. wild-type mice.

Authors:  Thibault Renoir; Eleni Païzanis; Malika El Yacoubi; Françoise Saurini; Naïma Hanoun; Maxette Melfort; Klaus Peter Lesch; Michel Hamon; Laurence Lanfumey
Journal:  Int J Neuropsychopharmacol       Date:  2008-07-09       Impact factor: 5.176

9.  Further evidence for the importance of 5-HT1A autoreceptors in the action of selective serotonin reuptake inhibitors.

Authors:  S Hjorth; S B Auerbach
Journal:  Eur J Pharmacol       Date:  1994-08-01       Impact factor: 4.432

10.  Growth retardation and altered autonomic control in mice lacking brain serotonin.

Authors:  Natalia Alenina; Dana Kikic; Mihail Todiras; Valentina Mosienko; Fatimunnisa Qadri; Ralph Plehm; Philipp Boyé; Larissa Vilianovitch; Reinhard Sohr; Katja Tenner; Heide Hörtnagl; Michael Bader
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-11       Impact factor: 11.205

View more
  36 in total

1.  Reduced vesicular monoamine transport disrupts serotonin signaling but does not cause serotonergic degeneration.

Authors:  Shawn P Alter; Kristen A Stout; Kelly M Lohr; Tonya N Taylor; Kennie R Shepherd; Minzheng Wang; Thomas S Guillot; Gary W Miller
Journal:  Exp Neurol       Date:  2015-09-30       Impact factor: 5.330

2.  Genetic depletion of brain 5HT reveals a common molecular pathway mediating compulsivity and impulsivity.

Authors:  Mariana Angoa-Pérez; Michael J Kane; Denise I Briggs; Catherine E Sykes; Mrudang M Shah; Dina M Francescutti; David R Rosenberg; David M Thomas; Donald M Kuhn
Journal:  J Neurochem       Date:  2012-04-13       Impact factor: 5.372

3.  Constitutive and Acquired Serotonin Deficiency Alters Memory and Hippocampal Synaptic Plasticity.

Authors:  Sebastian P Fernandez; Aude Muzerelle; Sophie Scotto-Lomassese; Jacques Barik; Agnès Gruart; José M Delgado-García; Patricia Gaspar
Journal:  Neuropsychopharmacology       Date:  2016-07-27       Impact factor: 7.853

4.  CAPS1 RNA Editing Promotes Dense Core Vesicle Exocytosis.

Authors:  Kotaro Miyake; Toshio Ohta; Hisako Nakayama; Nobutaka Doe; Yuri Terao; Eiji Oiki; Izumi Nagatomo; Yui Yamashita; Takaya Abe; Kazuko Nishikura; Atsushi Kumanogoh; Kouichi Hashimoto; Yukio Kawahara
Journal:  Cell Rep       Date:  2016-11-15       Impact factor: 9.423

Review 5.  Insights into the complex influence of 5-HT signaling on thalamocortical axonal system development.

Authors:  Esmee S B van Kleef; Patricia Gaspar; Alexandre Bonnin
Journal:  Eur J Neurosci       Date:  2012-05       Impact factor: 3.386

Review 6.  The 5-HT deficiency theory of depression: perspectives from a naturalistic 5-HT deficiency model, the tryptophan hydroxylase 2Arg439His knockin mouse.

Authors:  Jacob P R Jacobsen; Ivan O Medvedev; Marc G Caron
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2012-09-05       Impact factor: 6.237

7.  Activity of Raphé Serotonergic Neurons Controls Emotional Behaviors.

Authors:  Anne Teissier; Alexei Chemiakine; Benjamin Inbar; Sneha Bagchi; Russell S Ray; Richard D Palmiter; Susan M Dymecki; Holly Moore; Mark S Ansorge
Journal:  Cell Rep       Date:  2015-11-19       Impact factor: 9.423

8.  Postnatal growth defects in mice with constitutive depletion of central serotonin.

Authors:  Nicolas Narboux-Nême; Gaelle Angenard; Valentina Mosienko; Friederike Klempin; Pothitos M Pitychoutis; Evan Deneris; Michael Bader; Bruno Giros; Natalia Alenina; Patricia Gaspar
Journal:  ACS Chem Neurosci       Date:  2012-12-15       Impact factor: 4.418

9.  VMAT1 deletion causes neuronal loss in the hippocampus and neurocognitive deficits in spatial discrimination.

Authors:  P K Multani; R Hodge; M A Estévez; T Abel; H Kung; M Alter; B Brookshire; I Lucki; A H Nall; K Talbot; G A Doyle; F W Lohoff
Journal:  Neuroscience       Date:  2012-11-29       Impact factor: 3.590

Review 10.  Monoamine-sensitive developmental periods impacting adult emotional and cognitive behaviors.

Authors:  Deepika Suri; Cátia M Teixeira; Martha K Caffrey Cagliostro; Darshini Mahadevia; Mark S Ansorge
Journal:  Neuropsychopharmacology       Date:  2014-09-02       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.